Hypertriglyceridemia is defined as a value of fasting serum triglyceride over 150 mg/dl. 
Introduction
Hypertriglyceridemia is defined as a value of fasting serum triglyceride over 150 mg/dl. Clinical Practice Guideline published in 2012 by Berglund L et high triglyceridemia>500 mg/dl [2] . The previously mentioned classification of hypertriglyceridemia according to the international medical societies is presented in Table 1 . 
General considerations
The elevated values in plasma triglyceride may be the result of increased production from the liver and intestine or decreased peripheral catabolism by a reduced lipoprotein lipase activity. Two forms are described: primary and secondary hypertriglyceridemia [3] . Primary hypertriglyceridemia is relatively rare and in its etiology a gene mutation of lipoprotein lipase, the enzyme involved in the catabolism of lipids rich in triglycerides, is involved [4] . Secondary hypertriglyceridemia has many causes: fat diet, excessive alcohol intake, medical conditions (obesity, metabolic syndrome, hypothyroidism, diabetes mellitus, renal disease, autoimmune disease), medication (corticosteroids, estrogens, antiretroviral therapy, tamoxifen. antihypertensives, antipsychotic medications) [3] . The association between type 2 diabetes mellitus (T2DM) and dyslipidemia is a relatively common condition. The lipoprotein abnormalities commonly present in T2DM consist of hypertriglyceridemia, increased level of low-density lipoprotein (LDL) and decreased plasma in high density lipoproteins (HDL). Alterations in lipid profile in hypothyroidism are similar to those in T2DM, respectively serum total cholesterol, LDL-cholesterol and triglycerides are significantly increased, and HDL-cholesterol levels are reduced.
Mild and moderate hypertriglyceridemia increase the risk for cardiovascular events while severe and very severe hypertriglyceridemia increase the risk for acute pancreatitis.
There are numerous studies on the potential role of elevated triglyceride levels in promoting coronary events. In an issue published in 1992 of British Heart Journal entitled: "Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischemic heart disease in British men", Braiton D and coauthors report that plasma triglyceride levels predicts major cardiovascular and triglyceride concentration is a more important predictor than total cholesterol levels [5] . Ten years later Abdel-Maksoud MF and Hokanson JE after analyzing twenty-one studies including 65.863 men and 11.089 women evaluating the association between plasma triglycerides and cardiovascular disease, indicate that triglycerides levels are an independent predictor of cardiovascular disease [6] . The role of serum triglyceride levels as a risk factor for cardiovascular diseases was evaluated in a metaanalysis which included 26 studies conducted in the Asia-Pacific region. Data analysis highlights that serum triglycerides is an important and independent predictor of cardiovascular disease and stroke risk in the previously mentioned region [7] . Another study that evaluated the role of hypertriglyceridemia in the development of cardiovascular disease, included 13.953 men-age 26 to 45 years, also stated that a decrease in initially elevated triglyceride levels is associated with a decrease in cardiovascular risk [8] . A meta-analysis based on prospective studies, published by Hokanson JE and Austin MA in the Journal of Cardiovascular Risk concludes that: "Based on combined data from prospective studies, triglyceride is a risk factor for cardiovascular disease for both men and women in the general population, independent of HDL cholesterol" [9] . In a review published by Kannel WB and Vasan RS entitled "Triglycerides as vascular risk factors: New Epidemiologic Insights for Current Opinion in Cardiology" the authors mention the role of fasting and non-fasting triglycerides as vascular risk factors even in subjects with low LDLcholesterol [10] .
Severe and very severe hypertriglyceridemia is a risk factor in the occurrence of the acute pancreatitis. Acute pancreatitis is a condition with various etiologies: iatrogenic, genetic, gallstones, alcohol consumption, hypertriglyceridemia.
The role of hypertriglyceridemia in the pathogenesis of acute pancreatitis are not fully elucidated. The mechanism proposed for the occurrence of acute pancreatitis in patients with severe hypertriglyceridemia include: occlusion of the pancreatic capillaries by chylomicrontriglyceride-rich lipoprotein particles, which is followed by release of pancreatic lipase; pancreatic lipase hydrolyses triglyceride and generated enhanced concentration of free fatty acids, which can generate cell injury: elevated amylase levels, edema and hemorrhage [11, 12] . The degradation of lipoprotein to free fatty acids may generate a proinflammatory response. Inflammatory cytokines (interleukin-1β, interleukin-6) may be involved according to some studies in the early stage of acute pancreatitis induced by severe hypertriglyceridemia [13] [14] [15] . Table 2 .
Treatment of hypertriglyceridemia
Optimizing lifestyle (fat free diet, cessation of alcohol consumption, weight loss, exercise), control of diabetes and hypothyroidism are important measures in the tratment of very severe hypertriglyceridemia.
Conventional pharmacological therapy of hypertriglyceridemia includes: fibrates, niacin, statins, ezetimibe, omega-3-fatty acid. Fibrate therapy can reduce plasma triglycerides levels by modulation of the activity of peroxisome proliferator-activated receptor-α in the liver, with a decrease of hepatic secretion of very-lowdensity lipoprotein (VLDL) and increased lipolysis of plasma triglycerides [16] . Barter PJ and Rye KA state in an article published in 2006 in Circulation that fibrates significantly reduce plasma triglycerides levels and raise the HDLcholesterol levels [17] . Nicotinic acid inhibits the lipolysis in adipose tissue and reduced plasma fatty acids. Daily administration of 3 gr of nicotinic acid may lead to reduction of plasma triglyceride levels by 45% and increase plasma HDL-cholesterol [18] . Statins reduce levels of the cholesterol and may reduce triglycerides levels by inhibiting hydroxymethylglutaryl coenzyme A reductase [16] . Ezetimibe is a cholesterol absorption inhibitor that significantly reduce LDL-cholesterol, triglycerides levels and increase the HDL-cholesterol levels [16, 19] . Omega-3 fats may decrease triglycerides levels by 20% when administered with other triglyceride-lowering therapies [16, 20] . The proposed mechanism by which omega-3-fatty acid decrease triglycerides levels are decline in hepatic production of VLDL and the increase clearance of VLDL [21] . Our patient has been prescribed a combination of fenofibrate, statins and omega-3 fatty acids. Due to the fact that the patient did not respond to conventional therapy, plasmapheresis was considered. Plasmapheresis seems to be, according to the experts, a safe therapeutic option in patients with very severe hypertriglyceridemia but its effect is transient. The diseases treated with plasmapheresis are uncommon, most reports evidences are case reports or small case studies. There are currently no controlled trials to highlight benefits of plasmapheresis in treatment of very severe hypertriglyceridemia. The American Society of Apheresis guidelines recommend plasmapheresis for treatment of hypertriglyceridemia in the context of pancreatitis [28] . Plasmapheresis is an expensive treatment option in such medical emergencies and is available in specialized centers.
Conclusion
Patients with very severe hypertriglyceridemia that do not respond to conventional therapy can have benefits from plasmapheresis.
